https://www.ashatherapeutics.com/ourscience
Post-viral Illness (Long COVID & ME/CFS)
Mitochondrial Fragmentation is the Commonality
Post-viral illnesses are a set of chronic pathologies with multiple symptomatic profiles including ME/CFS and Long COVID.
Similar to approaches for AD and PD, ASHA-091 intervention in preclinical models of post-viral illness is proving efficacious. Interestingly, ASHA-091 was designed specifically as the first targeted therapy for ME/CFS and post-viral illness and has since proven to have a host of other therapeutic indications including AD and PD as highlighted above.
https://www.ashatherapeutics.com/post/me-cfs
https://twitter.com/user/status/1667632490213670915
https://www.heckmannlab.com/pi-bio
Post-viral Illness (Long COVID & ME/CFS)
Mitochondrial Fragmentation is the Commonality
Post-viral illnesses are a set of chronic pathologies with multiple symptomatic profiles including ME/CFS and Long COVID.
Similar to approaches for AD and PD, ASHA-091 intervention in preclinical models of post-viral illness is proving efficacious. Interestingly, ASHA-091 was designed specifically as the first targeted therapy for ME/CFS and post-viral illness and has since proven to have a host of other therapeutic indications including AD and PD as highlighted above.
https://www.ashatherapeutics.com/post/me-cfs
https://twitter.com/user/status/1667632490213670915
https://www.heckmannlab.com/pi-bio